TCR-MHC-peptide(s): in vivo veritas

Slides:



Advertisements
Similar presentations
Allo-HLA reactivity of virus-specific memory T cells is common by Avital L. Amir, Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate.
Advertisements

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.
RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.
Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan.
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes.
Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo by Ilze Bot, Jian Guo, Miranda Van Eck,
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Socializing Individualized T-Cell Cancer Immunotherapy
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells by Maria Therese.
Major Histocompatibility complex OR
GVHD-associated immunodeficiency: soil or seed?
Do HSCs divide asymmetrically?
Hydroxyurea makes inflammation “just right”?
Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,
“Vitamin hypothesis”: explanation for allergy increase?
Triple play of H pylori in ITP
Neonatal GATA1 mutant clones under the radar
Bulging glands? Blame it on B cells
Absence of biologically important Kaposi sarcoma–associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma.
by Venetia Bigley, Laura E. Spence, and Matthew Collin
It's all in the timing by Linda J. Bendall Blood
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma by Lotta.
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
How I treat elderly patients with myeloma
Nonmyeloablative conditioning for relapsed follicular lymphoma
Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.
FNAIT: the fetus pleads guilty!
T regulatory cells turn on T regulatory cells
Gnawing at Metchnikoff’s paradigm
Genetic sequence analysis of inherited bleeding diseases
Functional neutrophils from human ES cells
Engineering regulatory T cells against factor VIII inhibitors
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
Suppression, surprise: galectin-10 and Treg cells
Setting the table for macrophages
Antigen-induced regulatory T cells
Has the T cell bitten off more than it can chew?
Basophils take a slice of IRF8 pie
MicroRNAs: regulators of gene expression and cell differentiation
Rare cells predict GVHD
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma by Kay.
HU for acute treatment of sickle VOC?
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,
Gremlin: vexing VEGF receptor agonist
To the heart of the APS puzzle
Correlation of mouse gene expression with bacterial gene expression.
by Christine L. Kempton, and Amanda B. Payne
Changes throughout time in the lineage content of clones regenerated in secondary mice. Changes throughout time in the lineage content of clones regenerated.
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
HoxA9 directly regulates cell cycle control genes.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers by Paul J Neeson, Alexander James Davenport, Joseph A Trapani, Michael.
FCM and TCR γ gene rearrangement analysis in LGL leukemia.
Rituximab immunotherapy: it’s getting personal
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
In Memoriam: E. Donnall Thomas
by Honglin Chen, Paul Smith, Richard F. Ambinder, and S. Diane Hayward
by Andy Hsu, Hang Quach, Tsin Tai, H. Miles Prince, Simon J
Patient Tregs express normal levels of suppression.
A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.
by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
Investigation of reactivity of D14 HLA-A
Cold agglutinin disease
Presentation transcript:

TCR-MHC-peptide(s): in vivo veritas by Paul J. Martin Blood Volume 118(26):6731-6732 December 22, 2011 ©2011 by American Society of Hematology

Flow of work by Amir et al Flow of work by Amir et al.1 Peptide specificities presented in conjunction with HLA-A*0201 were identified for the clone with 2 specificities and for 6 of the clones with a single specificity. Flow of work by Amir et al.1 Peptide specificities presented in conjunction with HLA-A*0201 were identified for the clone with 2 specificities and for 6 of the clones with a single specificity. Experiments with silencing hairpin RNA sequences that suppressed specific gene expression confirmed that no other peptides were recognized by 4 of the 6 clones with single peptide specificities or by the clone with 2 peptide specificities. Two of the clones that recognized a single peptide were not tested in this type of experiment. Professional illustration by Paulette Dennis. Paul J. Martin Blood 2011;118:6731-6732 ©2011 by American Society of Hematology